In Law360, Attorneys Examine FDA Final Rule Amending Prescription Drug Advertising Regulations

In The News
December 13, 2023

In a Law360 article, life sciences regulatory & compliance partners Kellie Combs and Joshua Oyster and associate Jessica Band analyzed the U.S. Food and Drug Administration long-awaited final rule that amends the agency’s prescription drug advertising regulations addressing the presentation of the so-called “major statement” related to side effects and contraindication in TV and radio ads.

The article summarizes the key aspects of the final rule and important takeaways for marketers of prescription drugs.